Supernus Pharmaceuticals, Inc. · NASDAQ:SUPN

Armistice Capital, LLC reported a 9.28% stake in Supernus Pharmaceuticals, Inc. (Schedule 13G/A)

Event Mar 31, 2025 · Filed May 15, 2025

Armistice Capital, LLC reported a 9.28% stake in Supernus Pharmaceuticals, Inc., 5,196,000 shares, as a passive investor on Mar 31, 2025. Filed May 15, 2025 (Schedule 13G/A).

Stake
9.28%
Shares
5,196,000
Intent
Passive
What changed
Stake changed
Filed together
2 holders

The filing in full

HolderStakeShares
Armistice Capital, LLC9.28%5,196,000
Steven Boyd9.28%5,196,000

Source

View original at SEC

Related